Blog
RSS FeedPosted by Michael Wonder on 19 Mar 2020
Low prices won't keep new medicines out of Canada
19 March 2020 - There is no evidence of a link between pricing, research and development, and access to medicine. ...
Posted by Michael Wonder on 18 Mar 2020
COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO
18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...
Posted by Michael Wonder on 12 Mar 2020
CF Canada pleads with Ottawa to pave way for access to life-saving drugs
11 March 2020 - The national organisation that represents people who have cystic fibrosis is calling for changes to stop ...
Posted by Michael Wonder on 12 Mar 2020
AbbVie announces new formulary listings for Skyrizi in the treatment of moderate to severe plaque psoriasis
12 March 2020 - Non-Insured Health Benefits program lists Skyrizi on its formulary effective 21 February 2020. ...
Posted by Michael Wonder on 11 Mar 2020
Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!
10 March 2020 - As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases are ...
Posted by Michael Wonder on 08 Mar 2020
Price controls imposed by shortsighted politicians keep new life-saving drugs out
5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...
Posted by Michael Wonder on 05 Mar 2020
The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.
2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...
Posted by Michael Wonder on 04 Mar 2020
Revised procedure for the sponsor review of initial CADTH pCODR reports
4 March 2020 - Initial CADTH pCODR reports will now be issued to the sponsor four business days before the target ...
Posted by Michael Wonder on 03 Mar 2020
Hereditary amyloidosis community hopes positive funding recommendations for new treatments lead to swift access for patients
2 March 2020 - Hereditary Amyloidosis Canada is joined by the Regroupement québécois des maladies orphelines in commending the CADTH) and ...
Posted by Michael Wonder on 02 Mar 2020
Alberta expands coverage for cystic fibrosis drug
1 March 2020 - It's a step forward but there's a long way to go, says advocate. ...
Posted by Michael Wonder on 26 Feb 2020
N.S. father says drug-pricing 'chess game' cost his daughter her life
25 February 2020 - A father's fight to bring 'life-saving' drugs to Canada. ...
Posted by Michael Wonder on 24 Feb 2020
Alberta’s switch to biosimilar drugs may pose legal challenges for doctors
24 February 2020 - Prescribing cheaper medications for arthritis, diabetes or Crohn’s disease could be at odds with physicians’ legal requirement ...
Posted by Michael Wonder on 22 Feb 2020
'Heartbreaking' death of cystic fibrosis patient shines light on drug access issues
21 February 2020 - 23-year-old Chantelle Lindsay died Wednesday after she was denied life saving drug. ...
Posted by Michael Wonder on 20 Feb 2020
Canadian regulator considers changes to new drug pricing plan
20 February 2020 - Canada’s drug pricing agency is contemplating significant changes to how it will apply new regulations aimed at ...
Posted by Michael Wonder on 18 Feb 2020
CEADM applauds CADTH's decision to recommend an innovative depression medication for publicly-funded drug plans in Canada
18 February 2020 - Canadians for Equal Access to Depression Medication (CEADM) applauds the CADTH's recent decision recommending that the ...